Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
NCT00755781
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
284
Enrollment
INDUSTRY
Sponsor class
Conditions
Lung Transplant
Interventions
DRUG:
Cyclosporine Inhalation Solution (CIS)
Sponsor
APT Pharmaceuticals, Inc.